Mutations in PARK2 and PARK6 genes are responsible for the majority of hereditary Parkinson's disease cases. These genes encode the E3 ubiquitin ligase parkin and the protein kinase PTENinduced kinase 1 (PINK1), respectively. Together, parkin and PINK1 regulate the mitophagy pathway, which recycles damaged mitochondria following oxidative stress. Native parkin is inactive and exists in an autoinhibited state mediated by its ubiquitin-like (UBL) domain. PINK1 phosphorylation of serine 65 in parkin's UBL and serine 65 of ubiquitin fully activate ubiquitin ligase activity; however, a structural rationale for these observations is not clear. Here, we report the structure of the phosphorylated UBL domain from parkin. We find that destabilization of the UBL results from rearrangements to hydrophobic core packing that modify its structure. Altered surface electrostatics from the phosphoserine group disrupt its intramolecular association, resulting in poorer autoinhibition in phosphorylated parkin. Further, we show that phosphorylation of both the UBL domain and ubiquitin are required to activate parkin by releasing the UBL domain, forming an extended structure needed to facilitate E2-ubiquitin binding. Together, the results underscore the importance of parkin activation by the PINK1 phosphorylation signal and provide a structural picture of the unraveling of parkin's ubiquitin ligase potential. . Multiple studies show that in response to mitochondrial oxidative stress parkin activity is stimulated through phosphorylation by PINK1 (4, 5). This in turn facilitates parkin-mediated ubiquitination of several proteins at the outer mitochondrial membrane and signals the turnover of damaged mitochondria through the mitophagy pathway (6-8). Some mutations in parkin cause its dysfunction, leading to an accumulation of mitochondrial damage that appears to be especially detrimental in neurons, a potential cause for Parkinson's disease.Parkin belongs to the RBR subfamily of E3 ubiquitin ligases (9) that function by transferring Ub from an E2-conjugating enzyme to a substrate through an E3-Ub intermediate (10). These enzymes are structurally autoinhibited in their native states by unique accessory domains (11-13), indicating that RBR ligases must be activated to carry out their full ubiquitination potential. Specifically, parkin contains an N-terminal ubiquitin-like (UBL) domain shown to inhibit Ub ligase activity (11). Threedimensional structures of parkin show UBL associates with the C-terminal region (R0RBR) through both ionic and hydrophobic interactions, blocking the proposed E2 recognition site (14, 15). PINK1 stimulates parkin activity through phosphorylation of both Ub and parkin's UBL domain at an equivalent serine 65 position in sequence and structure (16)(17)(18)(19)(20)(21). Whereas each phosphorylation event can increase parkin activity independently, maximal activity is obtained when both parkin and Ub are phosphorylated (18,19). Phosphorylation of parkin at S65 increases parkin's affinity for phosphoubiquitin (pUb) (1...